Toggle navigation
Home
About Us
Meet the Team
Our Work with NICE
Our Services
Clients
Pharmaceutical Companies
Device Companies
National Health Organisations
Local Health and Public Sector Organisations
Other Organisations
Training
Resources
Publications
Webinars
Glossary
Case Studies
Tools and Models
Contact Us
YHEC Careers
Sign up to the newsletter
University of York
Everolimus Plus Exemestane Compared to Exemestane and Fulvestrant for the Treatment of ER+ HER2- Metastastic Breast Cancer in the United Kingdom – A Societal Perspective
Back to all publications